title: The evidence base for non-CF bronchiectasis is finally evolving.
authors.affiliation: Department of Respiratory Medicine, Mater Adult Hospital, South Brisbane, Queensland, Australia; Immunity, Infection, and Inflammation Program, Translational Research Institute, Mater Research Institute-University of Queensland, Woolloongabba, Queensland, Australia.
authors.forename: David J
authors.initials: DJ
authors.lastname: Serisier
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001987:Bronchiectasis / Q000188:drug therapy*; D003550:Cystic Fibrosis / Q000188:drug therapy*; D006801:Humans; D018942:Macrolides / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D018942:Macrolides
keywords: azithromycin; bacterial drug resistance; bronchiectasis; erythromycin; macrolide